Healthy Extracts (HYEX) Interest Expenses (2015 - 2026)

Healthy Extracts (HYEX) posted quarterly Interest Expenses of $246713.0 for Q4 2025, up 21.18% quarter-over-quarter from $203597.0 in Q3 2025.

Healthy Extracts (HYEX) Interest Expenses (2015 - 2026) Analysis & Trends

Healthy Extracts' Interest Expenses history runs 8 years deep, the most recent figure standing at $246713.0 for Q4 2025.

In Q4 2025, Interest Expenses changed N/A year-over-year to $246713.0; the TTM figure through Dec 2025 stood at $246713.0 (changed N/A YoY), while the FY2025 annual figure was $246713.0, up 127.26% from the prior year.
Interest Expenses for Q4 2025 stood at $246713.0, up from $203597.0 in the prior quarter.
The five-year high for Interest Expenses was $562157.0 in Q3 2023, with the low at $5926.0 in Q1 2023.
The 4-year median for Interest Expenses is $203597.0 (2025), against an average of $210394.2.
Peak annual rise in Interest Expenses reached 3969.39% in 2024, while the deepest fall reached 80.69% in 2024.
Healthy Extracts' Interest Expenses stood at $231810.0 in 2022, then tumbled by 85.9% to $32678.0 in 2023, then soared by 232.21% to $108561.0 in 2024, then jumped by 127.26% to $246713.0 in 2025.
Business Quant data shows HYEX's Interest Expenses at $246713.0 in Q4 2025, $203597.0 in Q3 2025, and $92310.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Expense (Qtr)
1	Haleon	43.94 Bn	42.97 Bn	-	-
2	Teva Pharmaceutical Industries	42.95 Bn	39.30 Bn	2.15 Bn	-
3	Zoetis	31.58 Bn	29.90 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.63 Bn	22.83 Bn	5.10 Bn	-400.56 Mn
5	United Therapeutics	22.16 Bn	19.49 Bn	683.80 Mn	2.90 Mn
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn	120.70 Mn
7	Neurocrine Biosciences	15.53 Bn	15.14 Bn	935.80 Mn	2.90 Mn
8	Elanco Animal Health	11.76 Bn	11.23 Bn	798.00 Mn	59.00 Mn
9	Dr Reddys Laboratories	10.11 Bn	9.95 Bn	-	-
10	Healthy Extracts	19.90 Mn	19.71 Mn	1.45 Mn	-

Download Data